Cencora, Inc. $COR Holdings Lowered by Strs Ohio

Strs Ohio lowered its stake in Cencora, Inc. (NYSE:COR) by 4.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,180 shares of the company’s stock after selling 2,506 shares during the quarter. Strs Ohio’s holdings in Cencora were worth $16,078,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Kemnay Advisory Services Inc. acquired a new position in shares of Cencora in the fourth quarter worth about $25,000. Oakworth Capital Inc. acquired a new stake in shares of Cencora during the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora in the 4th quarter valued at approximately $27,000. Archer Investment Corp boosted its stake in Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after purchasing an additional 47 shares during the period. Finally, Motiv8 Investments LLC acquired a new position in Cencora in the 4th quarter worth approximately $29,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Buying and Selling

In other news, Director Lauren M. Tyler bought 550 shares of the stock in a transaction on Monday, June 22nd. The shares were purchased at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This trade represents a 14.44% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.38% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on COR. UBS Group boosted their target price on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. William Blair initiated coverage on Cencora in a research report on Tuesday, April 28th. They issued a “market perform” rating for the company. Citigroup lowered their price target on Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Weiss Ratings lowered Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday. Finally, Evercore set a $360.00 price objective on Cencora in a research note on Wednesday, April 8th. Eleven investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $367.75.

Cencora Stock Down 0.0%

Cencora stock opened at $296.43 on Friday. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The firm has a market cap of $57.67 billion, a PE ratio of 22.73, a P/E/G ratio of 1.65 and a beta of 0.58. The firm’s 50 day moving average price is $277.91 and its two-hundred day moving average price is $320.37.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. During the same period last year, the business earned $4.42 EPS. The company’s quarterly revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, research analysts predict that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora announced that its Board of Directors has approved a stock buyback plan on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. Cencora’s dividend payout ratio (DPR) is presently 18.40%.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.